ALTIMMUNE, INC. (ALT)
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH
COHEN & CO INC. (COHN)
Cohen & Company Reports Second Quarter 2026 Financial Results
ISHARES CORE MSCI EAFE IMI INDEX ETF CAD HEDGED (BLK)
BlackRock Expands Tokenized Cash Platform with BSTBL OnChain Shares and BRSRV
UPSTART HOLDINGS, INC. (UPST)
Upstart Publishes July 2026 Originations and Latest UMI
NEXTAGE THERAPEUTICS LTD (NXTG)
Net Asset Value(s)
KAYNE ANDERSON ENERGY INFRASTRUCTURE FUND, INC. (KYN)
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.09 Per Share for August 2026
ELI LILLY & CO (LLY)
Lillys olomorasib receives U.S. FDAs Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
TARGET HOSPITALITY CORP. (TH)
Target Hospitality Announces Second Quarter 2026 Earnings Release and Conference Call Schedule
JEFFS'' BRANDS LTD (NEXR)
Nexera Enters into Letter of Intent for Exclusive Distribution Rights to Darknet Intelligence Platform for Data Centers
CYBIN INC. (HELP)
Helus Pharma Appoints Michael Halstead as Chief Executive Officer